Acuta Capital Partners’s Curis CRIS Stock Holding History

Acuta Capital Partners’s Portfolio CRIS Stock Details CRIS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1,919	Closed	-$8.69M	–	41
2021 Q1	$8.69M	Buy	1,919 +594	+45%	+$2.48M	3.13%	9
2020 Q4	$4.34M	Buy	+1,325	New	+$1.59M	1.18%	30

Other funds holding CRIS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

SCM

Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return

Acuta Capital Partners's CRIS Position: Q2 2021 in Review

Acuta Capital Partners sold out of Curis (CRIS) in Q2 2021, closing a stake of 1,919 shares — an estimated $8.69M sold.

Acuta Capital Partners first reported a position in CRIS in Q4 2020 and held it in 2 quarters. The position peaked at $8.69M in Q1 2021. 127 funds tracked by Wall St. Rank hold CRIS as of Q2 2021.

Acuta Capital Partners reported no remaining Curis position as of Q2 2021 after selling out during the quarter.
Acuta Capital Partners sold 1,919 Curis shares in Q2 2021, an estimated $8.69M.
Acuta Capital Partners first reported a position in Curis in Q4 2020 and held it in 2 quarters.
Acuta Capital Partners's Curis position peaked at $8.69M in Q1 2021.
127 funds tracked by Wall St. Rank held Curis as of Q2 2021.

Based on Acuta Capital Partners's 13F filing for Q2 2021, filed 16 Aug 2021.